CD4+ T helper cells and the role they play in viral control
暂无分享,去创建一个
[1] K. Mozdzanowska,et al. CD4+ T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells. , 1997, Virology.
[2] K. Cease,et al. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans , 1988, Nature.
[3] B. Moss,et al. Reduction of Simian-Human Immunodeficiency Virus 89.6P Viremia in Rhesus Monkeys by Recombinant Modified Vaccinia Virus Ankara Vaccination , 2001, Journal of Virology.
[4] C. Leclerc,et al. In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help. , 1991, Journal of immunology.
[5] D. Watkins,et al. Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques , 2000, Nature Medicine.
[6] G. Kelsoe,et al. Alternative pathways for the selection of antigen-specific peripheral T cells , 1996, Nature.
[7] D. Brooks,et al. Critical Role for CD4+ T Cells in Controlling Retrovirus Replication and Spread in Persistently Infected Mice , 1998, Journal of Virology.
[8] B. Chesebro,et al. Requirement for CD4+ T Cells in the Friend Murine Retrovirus Neutralizing Antibody Response: Evidence for Functional T Cells in Genetic Low-Recovery Mice , 1998, Journal of Virology.
[9] R. Zinkernagel,et al. Cd4+ T Cell Subsets during Virus Infection , 2000, The Journal of experimental medicine.
[10] C. Hallahan,et al. High-level HIV-1 viremia suppresses viral antigen-specific CD4+ T cell proliferation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[11] E. Daar,et al. Antibody from Patients with Acute Human Immunodeficiency Virus (HIV) Infection Inhibits Primary Strains of HIV Type 1 in the Presence of Natural-Killer Effector Cells , 2001, Journal of Virology.
[12] M. Ostrowski,et al. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses. , 2001, The Journal of infectious diseases.
[13] R. Paredes,et al. HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection , 2001, AIDS.
[14] E. Rosenberg,et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.
[15] R. Kurth,et al. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection , 1987, Journal of virology.
[16] Jeffrey A. Ledbetter,et al. How B and T cells talk to each other , 1994, Nature.
[17] J. Lieberman,et al. Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor. , 1994, AIDS research and human retroviruses.
[18] H. McFarland,et al. Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. , 1984, Journal of immunology.
[19] E. Rosenberg,et al. Immune control of HIV-1 after early treatment of acute infection , 2000, Nature.
[20] R M Zinkernagel,et al. Natural antibodies and complement link innate and acquired immunity. , 2000, Immunology today.
[21] J. Forman,et al. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes , 1982, The Journal of experimental medicine.
[22] I. Stroehmann,et al. Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones , 1988, Nature.
[23] A. Simon,et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. , 2000, Science.
[24] K. Überla,et al. Suppression of Acute Viremia by Short-Term Postexposure Prophylaxis of Simian/Human Immunodeficiency Virus SHIV-RT-Infected Monkeys with a Novel Reverse Transcriptase Inhibitor (GW420867) Allows for Development of Potent Antiviral Immune Responses Resulting in Efficient Containment of Infection , 2000, Journal of Virology.
[25] E. Ingulli,et al. Visualization of specific B and T lymphocyte interactions in the lymph node. , 1998, Science.
[26] S. Rowland-Jones,et al. Cellular immune responses to HIV , 2001, Nature.
[27] B. Walker,et al. Acute human immunodeficiency virus type 1 infection. , 1998, The New England journal of medicine.
[28] R. Koup,et al. Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection , 2001, Journal of Virology.
[29] C. Pitcher,et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression , 1999, Nature Medicine.
[30] Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine , 2001, Science.
[31] F. Ennis,et al. A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6 , 1992, Journal of virology.
[32] R. Ahmed,et al. T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses , 1988, Journal of virology.
[33] P. Klenerman,et al. The influence of antigenic variation on cytotoxic T lymphocyte responses in HIV-1 infection , 1998, Journal of Molecular Medicine.
[34] R. Ahmed,et al. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection , 1994, Journal of virology.
[35] H. Pircher,et al. Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protection. , 1999, Journal of immunology.
[36] S. Kent,et al. Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long‐term survivors of transfusion‐acquired HIV‐1 infection , 1997, AIDS.
[37] P. Lane,et al. Co-stimulation and selection for T-cell help for germinal centres: the role of CD28 and OX40. , 2000, Immunology today.
[38] J. Altman,et al. Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.
[39] D. Baarle,et al. Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma. , 2001, Blood.
[40] A. Townsend,et al. Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.
[41] A. Rothman,et al. Bystander Target Cell Lysis and Cytokine Production by Dengue Virus-Specific Human CD4+ Cytotoxic T-Lymphocyte Clones , 1999, Journal of Virology.
[42] P. Morrissey,et al. Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[43] P. Cresswell,et al. Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs. , 1997, Journal of immunology.
[44] H. Schuitemaker,et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.
[45] P. Doherty,et al. Clearance of an Influenza A Virus by CD4+ T Cells Is Inefficient in the Absence of B Cells , 1998, Journal of Virology.
[46] S. Varga,et al. Stability of virus-specific CD4+ T cell frequencies from acute infection into long term memory. , 1998, Journal of immunology.
[47] B. Rouse,et al. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. , 1995, Journal of immunology.
[48] J. Lifson,et al. Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA. , 2001, Virology.
[49] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[50] K. Steimer,et al. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. , 1989, The Journal of clinical investigation.
[51] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[52] D. Montefiori,et al. Polyvalent Envelope Glycoprotein Vaccine Elicits a Broader Neutralizing Antibody Response but Is Unable To Provide Sterilizing Protection against Heterologous Simian/Human Immunodeficiency Virus Infection in Pigtailed Macaques , 2001, Journal of Virology.
[53] I. Keet,et al. Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection. , 1999, AIDS research and human retroviruses.
[54] W. Heath,et al. Induction of a CD8+ Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4+ T Cell Help , 1997, The Journal of experimental medicine.
[55] E. Rosenberg,et al. Multiple Effector Functions Mediated by Human Immunodeficiency Virus-Specific CD4+ T-Cell Clones , 2001, Journal of Virology.
[56] Stephen P. Schoenberger,et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions , 1998, Nature.
[57] Kevin A. Robertson,et al. Regression of a Murine Gammaherpesvirus 68-Positive B-Cell Lymphoma Mediated by CD4 T Lymphocytes , 2001, Journal of Virology.
[58] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.
[59] M. Yasukawa,et al. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. , 1984, Journal of immunology.
[60] D. Burton,et al. Role of Antibodies in Controlling Viral Disease: Lessons from Experiments of Nature and Gene Knockouts , 2000, Journal of Virology.
[61] B. Fleischer. Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture , 1984, Nature.
[62] P. Kinchington,et al. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. , 1991, Journal of immunology.
[63] G. M. Ortiz,et al. The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection , 2001, AIDS.
[64] D. Richman,et al. T cell recognition of HIV synthetic peptides in a natural infection. , 1989, Journal of immunology.
[65] X. Jin,et al. Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease , 1993, The Journal of experimental medicine.
[66] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[67] M. Graham,et al. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection , 1994, The Journal of experimental medicine.
[68] P. Rácz,et al. Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected Rhesus macaques after short-term antiretroviral treatment. , 2001, Virology.
[69] R. Zinkernagel,et al. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice , 1994, Journal of virology.
[70] Stephen P. Schoenberger,et al. Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation , 2001, Nature Immunology.
[71] D. Nixon,et al. Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy. , 2000, The Journal of infectious diseases.
[72] T. Braciale,et al. Differences in antigen presentation to MHC class I-and class II- restricted influenza virus-specific cytolytic T lymphocyte clones , 1986, The Journal of experimental medicine.
[73] E. Reinherz,et al. Separation of functional subsets of human T cells by a monoclonal antibody. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[74] H. Katinger,et al. Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. , 1999, Immunity.
[75] P. Doherty,et al. Progressive Loss of Cd8 + T Cell-mediated Control of a ~/-herpesvirus in the Absence of Cd4 + T Cells , 1996 .
[76] P. Doherty,et al. Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium , 1996, Journal of virology.
[77] R. Rott,et al. Recognition of viral antigens by human influenza A virus-specific T lymphocyte clones. , 1985, Journal of immunology.
[78] P. Klenerman,et al. Impairment of Cd4+ T Cell Responses during Chronic Virus Infection Prevents Neutralizing Antibody Responses against Virus Escape Mutants , 2001, The Journal of experimental medicine.
[79] M. V. von Herrath,et al. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge , 1996, Journal of virology.
[80] Tahir A. Rizvi,et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection , 2000, Nature Medicine.
[81] R. Jaenisch,et al. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells , 1991, The Journal of experimental medicine.
[82] D. Brooks,et al. Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection , 1999, Nature Medicine.
[83] Richard A. Flavell,et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.
[84] Polly Matzinger,et al. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell , 1998, Nature.
[85] Susan M. Kaech,et al. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells , 2001, Nature Immunology.
[86] B. M. Flynn,et al. Containment of Simian Immunodeficiency Virus Infection: Cellular Immune Responses and Protection from Rechallenge following Transient Postinoculation Antiretroviral Treatment , 2000, Journal of Virology.
[87] S. Nikiforow,et al. CD4+ T-Cell Effectors Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation , 2001, Journal of Virology.
[88] C. Biron,et al. NK cells and NKT cells in innate defense against viral infections. , 2001, Current opinion in immunology.
[89] E. Reinherz,et al. Human cytotoxic T cell clones directed at autologous virus-transformed targets: further evidence for linkage of genetic restriction to T4 and T8 surface glycoproteins. , 1983, Journal of immunology.
[90] E. Rosenberg,et al. Association between Virus-Specific Cytotoxic T-Lymphocyte and Helper Responses in Human Immunodeficiency Virus Type 1 Infection , 1999, Journal of Virology.
[91] J. Wilson,et al. Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease. , 2000, The Journal of infectious diseases.
[92] J. Mascola,et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies , 2000, Nature Medicine.
[93] P. Scherle,et al. Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin , 1986, The Journal of experimental medicine.
[94] K. Peterson,et al. CD4+ T Cells and Gamma Interferon in the Long-Term Control of Persistent Friend Retrovirus Infection , 2001, Journal of Virology.